Odanacatib

製品コードS1115 バッチS111502

印刷

化学情報

Chemical Structure Synonyms MK-0822 Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C25H27F4N3O3S
分子量 525.56 CAS No. 603139-19-1
Solubility (25°C)* 体外 DMSO 100 mg/mL (190.27 mM)
Water Insoluble
Ethanol Insoluble
体内 （毎回新しく調製した物を用意してください）
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
4%DMSO Corn oil

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

 5.000mg/ml (9.51mM) Taking the 1 mL working solution as an example, add 40 μL of 125 mg/ml clear DMSO stock solution to 960 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

 0.800mg/ml (1.52mM) Taking the 1 mL working solution as an example, add 50 μL of 16 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
Clear solution
5% DMSO 95% Corn oil

この製剤はselleckのラボで検証済みです。上記の溶解方法がご要望を満たさない場合、selleckの営業担当までお問い合わせ頂ければ、個別の試験を行います。

 1.000mg/ml (1.90mM) Taking the 1 mL working solution as an example, add 50 μL of 20 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 Odanacatib is a potent, selective, and neutral inhibitor of cathepsin K (human/rabbit) with IC50 of 0.2 nM/1 nM, and demonstrated high selectivity versus off-target cathepsin B, L, S. Phase 3.
in vitro In vitro, Odanacatib shows the high inhibitory activity and selectivity on cathepsin K with IC50 values of 0.2 nM and 1 nM for human cathepsin K and rabbit cathepsin K, respectively. Furthermore, this compound also shows similar potencies in whole human cell enzyme occupancy assays with corrected IC50 of 5 nM. [1] A recent study shows that this chemical results in reduction of Osteoclast (OC) resorption activity by interrupting intracellular vesicular trafficking. [2]
in vivo In preclinical rats, Odanacatib (10 mg/kg) exhibits excellent pharmacokinetics with clearance (Cl: 2 mL kg-1 min-1), low volume of distribution (Vdss: 1.1 L kg-1), half-life (T1/2: 6 hours) and oral bioavailability (F: 8%), respectively. Besides, this compound also exhibits excellent metabolic stability in rat hepatocytes with a 96% recovery of the parent identity. [1] This chemical administrated by p.o. prevents bone loss in ovariectomized (OVX) rabbits in a dose-related manner. Moreover, it (9 µM/day) leads to a significant increase in proximal femur bone mineral density (BMD) (7.8%), femoral neck BMD (10.8%) and the greater trochanter BMD (6.5%). [3] In the estrogen-deficient, skeletally mature rhesus monkeys, long-term treatment with this compound effectively inhibits bone turnover without reducing osteoclast number and maintains normal biomechanical properties of the spine of OVX nonhuman primates. [4]
特徴 A potent, selective, and neutral cathepsin K inhibitor.

プロトコル(参考用のみ)

キナーゼアッセイ Enzyme Inhibition [1]
To measure enzyme activity, assays are carried out in 50 mM MES pH 5.5 containing 2.5 mM DTT, 2.5 mM EDTA, and 10% DMSO. IC50 values of Odanacatib are determined for human cathepsins K and for humanized rabbit cathepsin K using 2 μM of Z-Leu-Arg-AMC as substrate. Prior to the addition of substrate, different concentrations of this compound ranging from 100 μM to 0.2 nM are preincubated for 15 minutes with each enzyme (0.2 nM−1 nM) to allow the establishment of the enzyme−inhibitor complex. Substrate is then added and the enzyme activity measured fro the increase of fluorescence at 460 nm (λex = 355 nm). The final volume of the reaction is 100 uL. Assays are performed in 96-well plate format and the plate read using a Spectramax plate reader. The percent inhibition of the reaction is calculated from a control reaction containing only vehicle. IC50 curves are generated by fitting percent inhibition values to a four parameter logistic model.
動物実験 動物モデル Ovariectomized (OVX) rabbit model
投薬量 ≤9 µM/day
投与方法 Administered via p.o.

参考

  • https://pubmed.ncbi.nlm.nih.gov/18226527/
  • https://pubmed.ncbi.nlm.nih.gov/21718816/
  • https://pubmed.ncbi.nlm.nih.gov/20734451/
  • https://pubmed.ncbi.nlm.nih.gov/22113859/

カスタマーフィードバック

Data independently produced by , , Shandong University, 2014, Craniofacial Science.

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Calcium-dependent pathway as a primary cause of hypoxic RGC damage in monkey retinal explants [ PLoS One, 2025, 20(7):e0327246] PubMed: 40644465
Immune regulatory and anti-resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice [ Br J Pharmacol, 2024, 10.1111/bph.17312] PubMed: 39294929
Airway epithelial overexpressed CTSK induces airway remodeling through EMTU activation in asthma [ Authorea , 2023, ] PubMed: none
Oral microbial extracellular DNA initiates periodontitis through gingival degradation by fibroblast-derived cathepsin K in mice [ Commun Biol, 2022, 5(1):962] PubMed: 36104423
The CD200-CD200R axis promotes squamous cell carcinoma metastasis via regulation of cathepsin K [ Cancer Res, 2021, canres.3251.2020] PubMed: 34183355
The abnormal accumulation of heparan sulfate in patients with mucopolysaccharidosis prevents the elastolytic activity of cathepsin V [ Carbohydr Polym, 2021, 253:117261] PubMed: 33278943
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 [ Cell Chem Biol, 2021, S2451-9456(21)00213-0] PubMed: 33979649
Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells [ Cell, 2020, S0092-8674(20)31394-5] PubMed: 33147445
Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation [ JCI Insight, 2020, 5(20)133019] PubMed: 33055423
Cathepsin K regulates localization and secretion of Tartrate-Resistant Acid Phosphatase (TRAP) in TRAP-overexpressing MDA-MB-231 breast cancer cells. [ BMC Mol Cell Biol, 2020, 21(1):15] PubMed: 32188406

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。